Preventing antibodies to infliximab in patients with Crohn's disease: optimize not immunize.
Sandborn
William J
WJ
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000906:Antibodies / Q000097:blood; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology*; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage*; D000069285:Infliximab
D000893:Anti-Inflammatory Agents; D000906:Antibodies; D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab; D006854:Hydrocortisone